JP2000516572A5 - - Google Patents

Download PDF

Info

Publication number
JP2000516572A5
JP2000516572A5 JP1997540522A JP54052297A JP2000516572A5 JP 2000516572 A5 JP2000516572 A5 JP 2000516572A5 JP 1997540522 A JP1997540522 A JP 1997540522A JP 54052297 A JP54052297 A JP 54052297A JP 2000516572 A5 JP2000516572 A5 JP 2000516572A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997540522A
Other languages
English (en)
Japanese (ja)
Other versions
JP3745380B2 (ja
JP2000516572A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1997/002444 external-priority patent/WO1997043649A1/en
Publication of JP2000516572A publication Critical patent/JP2000516572A/ja
Publication of JP2000516572A5 publication Critical patent/JP2000516572A5/ja
Application granted granted Critical
Publication of JP3745380B2 publication Critical patent/JP3745380B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP54052297A 1996-05-14 1997-05-13 プリオンタンパク質に結合し、イソ型PrP▲上c▼とPrP▲上sc▼を識別することが可能なシャペロン Expired - Fee Related JP3745380B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96107677 1996-05-14
EP96107677.5 1996-05-14
PCT/EP1997/002444 WO1997043649A1 (en) 1996-05-14 1997-05-13 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrP?sc¿

Publications (3)

Publication Number Publication Date
JP2000516572A JP2000516572A (ja) 2000-12-12
JP2000516572A5 true JP2000516572A5 (cg-RX-API-DMAC7.html) 2005-01-13
JP3745380B2 JP3745380B2 (ja) 2006-02-15

Family

ID=8222782

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54052297A Expired - Fee Related JP3745380B2 (ja) 1996-05-14 1997-05-13 プリオンタンパク質に結合し、イソ型PrP▲上c▼とPrP▲上sc▼を識別することが可能なシャペロン

Country Status (6)

Country Link
US (2) US6451541B1 (cg-RX-API-DMAC7.html)
EP (1) EP0914614B1 (cg-RX-API-DMAC7.html)
JP (1) JP3745380B2 (cg-RX-API-DMAC7.html)
AT (1) ATE249046T1 (cg-RX-API-DMAC7.html)
DE (1) DE69724619T2 (cg-RX-API-DMAC7.html)
WO (1) WO1997043649A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1186662A3 (en) * 1996-05-29 2003-01-15 McGILL UNIVERSITY Prion binding proteins and uses thereof
US6617119B2 (en) 1997-02-21 2003-09-09 The Regents Of The University Of California Assay for specific strains of multiple disease related conformations of a protein
AU764888B2 (en) * 1997-02-21 2003-09-04 Regents Of The University Of California, The Assay for disease related conformation of a protein
US6620629B1 (en) 1997-02-21 2003-09-16 The Regents Of The University Of California Method for detecting prions
US6720355B2 (en) 1997-02-21 2004-04-13 The Regents Of The University Of California Sodium dodecyl sulfate compositions for inactivating prions
US6221614B1 (en) * 1997-02-21 2001-04-24 The Regents Of The University Of California Removal of prions from blood, plasma and other liquids
US6719988B2 (en) 1997-02-21 2004-04-13 The Regents Of The University Of California Antiseptic compositions for inactivating prions
US5891641A (en) * 1997-02-21 1999-04-06 The Regents Of The University Of California Assay for disease related conformation of a protein
US5977324A (en) * 1998-02-20 1999-11-02 The Regents Of The University Of California Process for concentrating protein with disease-related conformation
US6214565B1 (en) 1998-10-09 2001-04-10 The Regents Of The University Of California Assay for disease related conformation of a protein and isolating same
US7041807B1 (en) 1999-06-23 2006-05-09 Caprion Pharmaceuticals, Inc. Antibodies to a YYX epitope of a mammalian prion protein
JP2003514773A (ja) * 1999-09-28 2003-04-22 ウニヴェルジテート チューリッヒ 血清及び血漿中のプリオン結合活性を有する因子並びに伝染性海綿状脳障害を検出するための薬剤
EP1216417A1 (de) * 1999-09-28 2002-06-26 Evotec OAI AG Quantitative analyse und typisierung subzellulärer partikel
MXPA03011000A (es) 2001-05-31 2004-02-27 Arete Associates Metodo de sensor de proteinas deformadas.
US20050026165A1 (en) 2001-05-31 2005-02-03 Cindy Orser Detection of conformationally altered proteins and prions
CA2454768A1 (en) * 2001-08-10 2003-02-20 Medical Research Council Molecule
ATE544780T1 (de) * 2002-04-09 2012-02-15 Scripps Research Inst Hybrid-polypeptide mit eingefügten sequenzmotiven und ihre verwendungen
US20040072236A1 (en) * 2002-09-27 2004-04-15 Neil Cashman PrPSc -interacting molecules and uses thereof
ES2375958T3 (es) * 2002-12-03 2012-03-07 Pathogen Removal And Diagnostic Technologies, Inc. Ligandos de prote�?nas priones y procedimientos de uso.
NZ543371A (en) * 2003-04-04 2008-04-30 Pathogen Removal And Diagnosti Prion protein binding materials and methods of use
JP5162250B2 (ja) * 2005-01-13 2013-03-13 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド プリオン特異的ペプチド試薬を使用するelisaアッセイ
WO2006088823A2 (en) * 2005-02-15 2006-08-24 Adlyfe, Inc. Method for detecting misfolded proteins and prions
WO2007089591A2 (en) * 2006-01-27 2007-08-09 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for high throughput screening of pharmacological chaperones
CN101802609A (zh) * 2006-07-28 2010-08-11 阿德利夫股份有限公司 用于诊断和治疗的肽探针

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1262896B (it) * 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
WO1993023432A1 (en) * 1992-05-15 1993-11-25 New York University Soluble prion polypeptides, and methods for detecting and purifying thereof
US5565186A (en) * 1994-05-13 1996-10-15 The Regents Of The University Of California Method of detecting prions in a sample and transgenic animal used for same
US5688651A (en) * 1994-12-16 1997-11-18 Ramot University Authority For Applied Research And Development Ltd. Prevention of protein aggregation
ATE242005T1 (de) * 1994-12-21 2003-06-15 Yeda Res & Dev P277 peptidanaloge, pharmazeutische zusammenstellung davon zur behandlung und diagnose von diabetes
IL114407A0 (en) * 1995-06-30 1995-10-31 Yeda Res & Dev Novel peptides and pharmaceutical compositions comprising them

Similar Documents

Publication Publication Date Title
JP2000502280A5 (cg-RX-API-DMAC7.html)
JP2000501771A5 (cg-RX-API-DMAC7.html)
JP2001507199A5 (cg-RX-API-DMAC7.html)
JP2000501599A5 (cg-RX-API-DMAC7.html)
JP2000501018A5 (cg-RX-API-DMAC7.html)
JP2001508625A5 (cg-RX-API-DMAC7.html)
JP2000501324A5 (cg-RX-API-DMAC7.html)
JP2000502472A5 (cg-RX-API-DMAC7.html)
JP2000501338A5 (cg-RX-API-DMAC7.html)
JP2000501825A5 (cg-RX-API-DMAC7.html)
JP2000500874A5 (cg-RX-API-DMAC7.html)
JP2000502485A5 (cg-RX-API-DMAC7.html)
JP2000502425A5 (cg-RX-API-DMAC7.html)
JP2000502568A5 (cg-RX-API-DMAC7.html)
JP2000501774A5 (cg-RX-API-DMAC7.html)
JP2000500912A5 (cg-RX-API-DMAC7.html)
JP2000502570A5 (cg-RX-API-DMAC7.html)
JP2001501952A5 (cg-RX-API-DMAC7.html)
JP2000501876A5 (cg-RX-API-DMAC7.html)
JP2001507821A5 (cg-RX-API-DMAC7.html)
JP2001502260A5 (cg-RX-API-DMAC7.html)
JP2000501744A5 (cg-RX-API-DMAC7.html)
JP2001518003A5 (cg-RX-API-DMAC7.html)
JP2000501229A5 (cg-RX-API-DMAC7.html)
JP2001503277A5 (cg-RX-API-DMAC7.html)